News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Paolo Tarantino: Dato-DXd is the Latest ADC to be Approved for Treating HR+/HER2- MBC
Paolo Tarantino/X
Jun 5, 2025, 08:58

Paolo Tarantino: Dato-DXd is the Latest ADC to be Approved for Treating HR+/HER2- MBC

Paolo Tarantino, 2025 Yvonne ‘Top Voice’ Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:

“Dato-DXd is the latest ADC to be approved for treating HR+/HER2- MBC, joining two other topo1 ADCs (T-DXd, SG).
How should we sequence these agents?
We conducted multiple rounds of polling to generate consensus within the Dana-Farber Cancer Institute Breast Oncology group.
The resulting consensus document is now published.”

Read More.

Dato-DXd

More posts featuring Paolo Tarantino on OncoDaily.

 

cancer Dana-Farber Cancer Institute Dato-DXd Datopotamab deruxtecan (Dato-DXd) OncoDaily Oncology Paolo Tarantino Paolo Tarantino: Dato-DXd is the Latest ADC to Be Approved for Treating HR+/HER2- MBC
Special Coverage
Blog
Jun 26, 2025, 19:30
Getting Ready to Make the Most of Upcoming Events - EORTC
Blog
Jun 26, 2025, 19:22
Tobacco Taxation Gains Momentum in Kenya and Uganda Through Civil Society Mobilisation - UICC
Blog
Jun 26, 2025, 18:56
Late Breaking Abstract Submission Is Open - European Association of Neuro-Oncology
Blog
Jun 26, 2025, 18:44
Winan van Houdt: Pleased to Be Invited to the First Colombian Conference of Surgical Oncology
Positive
Jun 26, 2025, 18:34
Improving Life After Cancer for Survivors of Childhood and Adolescent Cancer - SIOP Europe
Blog
Jun 26, 2025, 18:18
Vote for Xploro to Win People’s Choice Award at CancerX Accelerator 2025 - World Child Cancer USA
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski